Annual Meeting

Annual meeting to highlight JLR junior associate editors

George Carman Robert V. Stahelin
Dec. 1, 2019

The Journal of Lipid Research recently recruited four outstanding early-career scientists to serve as junior associate editors: Raymond Blind of the Vanderbilt University School of Medicine, Gissette Reyes–Soffer of the Columbia University Irving Medical Center, Brandon Davies of the University of Iowa Carver College of Medicine and Rotonya Carr of the University of Pennsylvania Perelman School of Medicine.

The 2020 JLR speakers will present their work at the 2021 ASBMB Annual Meeting, 1:45–3 p.m., Tuesday, April 27.

Find out about registering for the annual meeting here.

The JLR instituted the junior associate editors program to facilitate development of review skills and associated editorial activities. Since their appointments, these four junior AEs not only have been involved with the review process but also have organized a series of virtual issues highlighting the cutting-edge research published by the journal on lipoprotein clearance, sphingolipids and lipoprotein (a). A fourth virtual issue is due to be published this month.

When the American Society for Biochemistry and Molecular Biology Meetings Committee asked us to organize the JLR session for the upcoming annual meeting in San Diego, it seemed obvious that there was no better way to highlight the journal’s commitment to early-career scientists than to have a session centered around our junior AEs. The JLR session, titled “Lipid Diversity and Disease: Spotlight on Journal of Lipid Research Junior Associate Editors,” will highlight their lipid-based research ranging from basic to clinical studies.

As co-chairs of this JLR session, we invite you to read in the following pages about our junior AEs and the exciting work they will present on April 7 at the 2020 ASBMB Annual Meeting.

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
George Carman

George M. Carman is the founding director of the Rutgers Center for Lipid Research, a Journal of Lipid Research associate editor and co-director of the ASBMB Lipid Research Division.

Robert V. Stahelin

Robert V. Stahelin is the Retter professor of pharmacy and a professor of medicinal chemistry and molecular pharmacology at Purdue University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

A chapter builds connections
Student Chapters

A chapter builds connections

Nov. 27, 2023

The ASBMB helped Lauryn Ridley build a community among her peers: “It’s outside the classroom, and you can be free to relate to other people who are going through the same things that you’re going through.”

Community Day broadens impact of DiscoverBMB
Annual Meeting

Community Day broadens impact of DiscoverBMB

Nov. 27, 2023

The ASBMB Science Outreach and Communication Committee is organizing its second annual event to inspire local high school students — this time in San Antonio.

Advocating for change in science
Feature

Advocating for change in science

Nov. 23, 2023

ASBMB trainees harness their training and life experience to reshape science policy.

How public policy work amplifies our impact
Essay

How public policy work amplifies our impact

Nov. 23, 2023

ASBMB Today contributor Oluwadamilola “Dami” Oke describes her journey to advocacy and shares thoughts from a mentor who guided her.

‘The implosion of the large laboratory business model’
Interview

‘The implosion of the large laboratory business model’

Nov. 22, 2023

NIGMS Director Jon Lorsch talks about challenges for researchers, what the agency is doing to help early-career scientists and the future of academic labs.

Addressing disparities in research and beyond
Research Spotlight

Addressing disparities in research and beyond

Nov. 22, 2023

ASBMB Maximizing Access Committee member Stephen D. Williams is a postdoc who hopes to take his concerns about health care equity into a career in industry.